The guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations
WHO has published a new consolidated guidelines on HIV, viral hepatitis and STI prevention, diagnosis, treatment and care for key populations.
The guidelines outline a public health response to HIV, viral hepatitis and sexually transmitted infections (STIs) for 5 key populations (men who have sex with men, trans and gender diverse people, sex workers, people who inject drugs and people in prisons and other closed settings).
Erika Castellanos, Director of programmes at GATE (the global Action for Trans Equality), who was the co-chair of the WHO Guidelines Development Group said, “Key populations must be prioritized, in every setting and this means as outlined in these new guidelines, planning to reach them first with prevention, testing and treatment as well as prioritising key populations in funding programmes.”
Meg Doherty, Director of WHO’s Global HIV, Hepatitis and STI Programmes said, “The new data from UNAIDS show that around 70 per cent of new HIV infections occur among key populations and their partners. In most countries, limited access, inadequate coverage and poor quality of services for key populations continue to undermine responses to HIV, viral hepatitis and STIs. All countries should prioritize reaching these key populations and supporting key population communities to lead the response and provide equitable, accessible and acceptable services to these groups.”
In addition to highlighting the need to address structural barriers and provide prioritised packages of health services for each of the 5 populations, new recommendations are made for the delivery of services such as virtual/on-line interventions and the critical role of peer navigators to guide members of key population groups through health services.
Other new areas of recommendations include addressing chemsex, frequency of hepatitis C virus (HCV) testing for people at ongoing risk of infection and providing treatment for HCV without delay to people with recently acquired HCV infection and ongoing risk. These guidelines also acknowledge that behavioural interventions aimed at changing behaviours which tend to be prioritised in many settings have no impact on incidence of HIV, viral hepatitis and STIs or on behaviour change.